U.S. Rep. Mary Miller (R-Mahomet) addressed the implications of federal rules on chemical abortion drug distribution for state authority following the Supreme Court’s temporary order on mifepristone access.
The Supreme Court issued a one-week administrative stay that temporarily restored the Food and Drug Administration rule allowing the abortion pill mifepristone to be sent by mail, pausing a lower court ruling from the Fifth Circuit that had reinstated an in-person dispensing requirement, as reported by CNN.
“The murder-for-profit abortion industry should not be allowed to bypass state laws that protect life by shipping dangerous chemical abortion drugs across state lines,” Miller wrote in a post on X.
Illinois maintains some of the most expansive abortion access laws in the nation and serves as a destination state for out-of-state patients seeking services. In 2025, clinicians provided an estimated 32,000 abortions to out-of-state residents in Illinois, according to the Guttmacher Institute.
Another study from the Guttmacher Institute showed that medication abortion accounted for 65% of all clinician-provided abortions nationwide in 2023 and remained the dominant method in 2025 with an estimated 1,126,000 total abortions performed by clinicians.
Federal regulators approved mifepristone in 2000 for early pregnancy termination and later eased dispensing requirements, including permanent removal of the in-person visit mandate. Post-marketing surveillance has documented adverse events associated with the drug regimen, according to the FDA.
Miller has represented Illinois’s 15th congressional district since 2021. She chairs the Congressional Family Caucus and belongs to the House Freedom Caucus. Miller graduated from Eastern Illinois University with a degree in business management, according to her biography.
